ANTHONY COSTALES to Female
This is a "connection" page, showing publications ANTHONY COSTALES has written about Female.
Connection Strength
0.225
-
Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial. Gynecol Oncol. 2024 06; 185:143-147.
Score: 0.033
-
Effect of platinum sensitivity on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent epithelial ovarian cancer. J Gynecol Obstet Hum Reprod. 2021 May; 50(5):101844.
Score: 0.025
-
Characterizing the efficacy and trends of adjuvant therapy versus observation in women with early stage (uterine confined) leiomyosarcoma: a National Cancer Database study. J Gynecol Oncol. 2020 May; 31(3):e21.
Score: 0.025
-
Radical Trachelectomy for Early Stage Cervical Cancer. Curr Treat Options Oncol. 2018 11 19; 19(12):75.
Score: 0.023
-
2-Octylcyanoacrylate for the prevention of anastomotic leak. J Surg Res. 2018 06; 226:166-172.
Score: 0.022
-
Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia. Gynecol Oncol. 2014 Dec; 135(3):451-4.
Score: 0.017
-
Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. Gynecol Oncol. 2013 Jun; 129(3):513-6.
Score: 0.015
-
Development and Implementation of a Personal Virtual Assistant for Patient Engagement and Communication in Postsurgical Cancer Care: Feasibility Cohort Study. JMIR Cancer. 2025 Feb 18; 11:e64145.
Score: 0.009
-
Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer. Gynecol Oncol. 2021 09; 162(3):645-651.
Score: 0.007
-
Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Gynecol Oncol. 2021 08; 162(2):368-374.
Score: 0.007
-
Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registry. Int J Gynecol Cancer. 2021 07; 31(7):1021-1030.
Score: 0.007
-
Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Gynecol Oncol. 2021 05; 161(2):389-395.
Score: 0.007
-
Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancer. Gynecol Oncol. 2021 04; 161(1):194-201.
Score: 0.007
-
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer. Gynecol Oncol. 2021 01; 160(1):45-50.
Score: 0.006
-
A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology. Gynecol Oncol. 2020 09; 158(3):794-802.
Score: 0.006
-
Intestinal Surgery in Gynecologic Oncology: Are We Training for the Future? Int J Gynecol Cancer. 2018 06; 28(5):983-988.
Score: 0.005
-
Is it equivalent? Evaluation of the clinical activity of single agent Lipodox? compared to single agent Doxil? in ovarian cancer treatment. J Oncol Pharm Pract. 2016 Aug; 22(4):599-604.
Score: 0.005